Related Experiment Video
Updated: Jun 3, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
[Antimicrobial treatment of polymicrobial infections]
Milorad Pavlović1, Jelena Nikolić
1Klinika za infektivne i tropske bolesti, Klinicki centar Srbije, Beograd, Koste Todorovića.
Introduction:
Polymicrobial infections are concomitant or successive infections caused by two or more microorganisms at the same site. The most common types of these infections include orofacial, gastro-intestinal, pelvic (PID) infections, solid organ abscesses (brain, liver, lungs), chronic infections (sinusitis, mastoiditis), skin and soft tissue infections ("diabetic foot", cellulitis, necrotic fasciitis), sepsis.
Choice Of Therapy:
The most important clues in the therapeutic choice include isolation of the causative agents and empirical data concerning the most common microorganisms of'the affected region. The sensitivity of the most common anaerobic pathogen in polymicrobial infections--B.fragillis, is closely monitored, and according to the latest data it is maintained as such to metronidazole, carbapenems. aminopenicillins with beta-lactamase inhibitors and tigecycline, fluoroquinolones.
Conclusion:
However it must be emphasized that antimicrobial therapy represents only one aspect of the treatment in this type of infections, and can not replace a more adequate multi-disciplinary approach, which often includes surgical treatment.
Insights
Polymicrobial infections involve multiple microbes and require targeted antimicrobial therapy. Effective treatment also necessitates a comprehensive, multidisciplinary approach, often including surgery.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Context:
- Polymicrobial infections, involving two or more microorganisms at a single site, are prevalent in various clinical settings, including orofacial, gastrointestinal, pelvic, and skin infections.
- These infections pose significant therapeutic challenges due to the complexity of causative agents and potential for antimicrobial resistance.
Purpose:
- To outline key considerations for selecting antimicrobial therapy in polymicrobial infections.
- To highlight the importance of monitoring the sensitivity of key pathogens, such as Bacteroides fragilis, to commonly used antibiotics.
Summary:
- Therapeutic choices for polymicrobial infections depend on identifying causative agents and understanding regional microbial prevalence.
- Bacteroides fragilis, a common anaerobic pathogen, remains sensitive to metronidazole, carbapenems, aminopenicillins with beta-lactamase inhibitors, tigecycline, and fluoroquinolones.
Impact:
- Antimicrobial therapy is a crucial component but not the sole solution for polymicrobial infections.
- A multidisciplinary treatment strategy, frequently incorporating surgical intervention, is essential for optimal patient outcomes.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Antimicrobial Effectiveness

